Live tape
Top 8, mentions 7d6,889GOOGL1,293 mentions▲ +0.03AAPL1,167 mentions▲ +0.07NKE1,034 mentions+0.02NVDA799 mentions▲ +0.07ORCL740 mentions▲ +0.06META718 mentions▲ +0.05TSLA618 mentions▲ +0.06VOO520 mentions▲ +0.09

Equity · Industrials

MTZ

MasTec, Inc. · NYSE

$232 −3.62% 1D Finazon · prior-day close · Sep 10, 2026
Price · Chart
Our own end-of-day closes 57 sessions
$500 $200 15 Jun 10 Sep

The line runs $372.17 on 15 June through $232 on 10 September, on a scale from $200 to $500. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of MTZ over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 57 sessions over that window: $372.17 on 15 June 2026 through $232 on 10 September 2026.

Market cap $18.6B
P/E (TTM) 41.8
52-week range $174.97 – $444
Avg volume 226.7K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 11, 2026

MTZ insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 14 Aug 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 12

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
14 Aug 2026 Campbell C Robert Director Award 139
14 Aug 2026 Csiszar Ernst N Director Award 152
14 Aug 2026 Csiszar Ernst N Director Tax withheld 34 $10K
14 Aug 2026 Dwyer Robert J Director Award 139
14 Aug 2026 Dwyer Robert J Director Tax withheld 31 $9K
14 Aug 2026 JOHNSON JULIA L Director Award 139
14 Aug 2026 Parker Ava L Director Award 177
14 Aug 2026 Parker Ava L Director Tax withheld 20 $6K
14 Aug 2026 Spiro Alex Director Award 139
14 Aug 2026 Palomarez Javier Alberto Director Award 139
14 Aug 2026 Palomarez Javier Alberto Director Tax withheld 31 $9K
14 Aug 2026 Miranda Manuel Benito Director Award 152

MTZ reported financials

SEC EDGAR XBRL

MTZ reported revenue of $14.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $399.0M.

Figure Reported Period
Revenue $14.3B 31 Dec 2025 fiscal year
Net income $399.0M 31 Dec 2025 fiscal year
Diluted EPS $5.07 31 Dec 2025 fiscal year
Total assets $10.9B 30 Jun 2026 at period end
Total equity $3.5B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

MTZ earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $1.65 $4.37B
31 Mar 2026 Q1 2026 $0.77 $3.83B
31 Dec 2025 FY 2025 $5.07 $14.30B
30 Sep 2025 Q3 2025 $2.04 $3.97B
30 Jun 2025 Q2 2025 $1.09 $3.54B
31 Mar 2025 Q1 2025 $0.13 $2.85B
31 Dec 2024 FY 2024 $2.06 $12.30B
30 Sep 2024 Q3 2024 $1.21 $3.25B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

MTZ institutional holders

SEC Form 13F

12 of the 45 institutional funds we track reported a MTZ position for the quarter ended 30 Jun 2026 — a combined $1.4B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Lone Pine Capital Held (±25%) −12.1% shares 1,345,157 $559.7M
AQR Capital Management Held (±25%) −0.4% shares 657,603 $273.6M
Coatue Management Held (±25%) −11.4% shares 517,250 $215.2M
Third Point Held (±25%) −9.4% shares 290,000 $120.7M
D. E. Shaw & Co. Added +237.8% shares 180,243 $75.0M
Point72 Asset Management Trimmed −63.9% shares 156,309 $65.0M
Two Sigma Investments Held (±25%) +24.7% shares 125,069 $52.0M
Millennium Management Trimmed −91.3% shares 43,898 $18.3M
Soros Fund Management Added +110.5% shares 8,275 $3.4M
Man Group Held (±25%) −19.5% shares 7,544 $3.1M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

MTZ fails-to-deliver

SEC CNS data

On 11 Aug 2026, 5 shares of MTZ failed to deliver (about $1K).

Settlement date Shares failed Notional % of shares out
11 Aug 2026 5 $1K <0.001%

Source: SEC fails-to-deliver (CNS) data